GAITHERSBURG, Md.--(BUSINESS WIRE)--MagBio Genomics, Inc., a company that focuses on magnetic bead-based nucleic acids sample preparation products for sequencing and molecular diagnostics, announces ...
Prognostic significance of preoperational circulating tumor DNA detection in early-stage NSCLC using a tissue-free blood test. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback